Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

Clinical trial NCT04820751 · UNKNOWN

Trial details

NCT number: NCT04820751
Sponsor: Ciusss de L'Est de l'Île de Montréal
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Viral Pneumonia Serotonin Syndrome Platelet Dysfunction

Start date: 2021-04-10
Primary completion: 2021-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.